We are live on ! Find out more
AHPAU

Avista Healthcare Public Acquisition Corp.Units

Delisted

AHPAU was delisted on the 30th of October, 2018.

4 hedge funds and large institutions have $14M invested in Avista Healthcare Public Acquisition Corp.Units in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 44 (0)

42% less capital invested

Capital invested by funds: $24.3M → $14M (-$10.3M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$10.2M

AHPAU Hedge Fund Activity: Q2 2018 in Review

4 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Avista Healthcare Public Acquisition Corp.Units (AHPAU) for Q2 2018, worth a combined $14M — down 42% from $24.3M a quarter earlier.

Fund positioning in AHPAU was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Polar Asset Management Partners, cutting an estimated $10.2M.

  • 4 institutional investors held Avista Healthcare Public Acquisition Corp.Units (AHPAU) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $14M of Avista Healthcare Public Acquisition Corp.Units stock for Q2 2018, down 42% quarter-over-quarter.
  • 0 funds opened new Avista Healthcare Public Acquisition Corp.Units positions in Q2 2018 and 0 closed out.
  • The largest Avista Healthcare Public Acquisition Corp.Units seller in Q2 2018 was Polar Asset Management Partners, an estimated $10.2M sold.

Based on aggregated 13F filings for Q2 2018.